scholarly journals Strong antibody response after a first dose of a SARS‐CoV‐2 mRNA‐based vaccine in kidney transplant recipients with a previous history of COVID‐19

2021 ◽  
Author(s):  
Ilies Benotmane ◽  
Gabriela Gautier ‐Vargas ◽  
Floriane Gallais ◽  
Pierre Gantner ◽  
Noelle Cognard ◽  
...  
Keyword(s):  
Antibody Response ◽  
Kidney Transplant ◽  
Previous History ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Strong Antibody Response ◽  
History Of

Safety and Antibody Response to BNT162b2 and ChAdOx1 nCoV-19 Vaccines in Kidney Transplant Recipients

2021 ◽  
Vol 05 (04) ◽  
Author(s):  
Ali AlShaqaq ◽  
Maher AlDemerdash ◽  
Abdulnaser AlAbadi ◽  
Baher Elgadaa ◽  
Najib Musaied ◽  
...  
Keyword(s):  
Antibody Response ◽  
Kidney Transplant ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients

scholarly journals Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients

2021 ◽  
Author(s):  
Roman Reindl-Schwaighofer ◽  
Andreas Heinzel ◽  
Manuel Mayrdorfer ◽  
Rhea Jabbour ◽  
Thomas M. Hofbauer ◽  
...  
Keyword(s):  
Antibody Response ◽  
Kidney Transplant ◽  
Vaccine Dose ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients

scholarly journals Identification of Risk Factors for Multiple Non-Melanoma Skin Cancers in Italian Kidney Transplant Recipients

Medicina ◽  
2019 ◽  
Vol 55 (6) ◽  
pp. 279 ◽  
Author(s):  
Elisa Zavattaro ◽  
Paolo Fava ◽  
Federica Veronese ◽  
Giovanni Cavaliere ◽  
Daniela Ferrante ◽  
...  
Keyword(s):  
Risk Factors ◽  
Kidney Transplant ◽  
Organ Transplant ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Skin Cancers ◽  
Increased Risk ◽  
History Of ◽  
Solar Lentigo ◽  
Melanoma Skin

Background and objectives: Non-melanoma skin cancers (NMSCs) represent the most frequently encountered malignancy in organ transplant recipients and their incidence increases proportionally to the duration of immunosuppression. Furthermore, patients of this group often develop multiple and more aggressive cancers and, to date, risk factors for the development of multiple NMSCs have not been yet established. The present study aimed to identify risk factors for multiple NMSCs in a cohort of Italian kidney transplant recipients (KTRs). Materials and Methods: We consecutively included all KTRs referring to two post-transplant outpatient clinics of North-Western Italy between 2001 and 2017. In this cohort, we evaluated different clinical (endogenous and exogenous) risk factors in order to establish their correlation with NMSCs. Results: 518 KTRs were included, of which 148 (28.6%) developed keratinocyte cancers, with a single tumor in 77 subjects, two skin cancers in 31 patients, 3 in 21 patients, whereas at least 4 NMSCs developed in 19 KTRs. We observed an increased risk of the development of cutaneous neoplasms for the male gender, old age at transplantation (>50 years), light phototype, solar lentigo, history of sunburns, or chronic actinic damage. Considering patients affected by multiple keratinocyte neoplasms, we observed a significant association of actinic damage and solar lentigo with an increased risk of NMSCs; their significance was confirmed even at the multivariable model. Conclusions: Our results confirm the role played by chronic cutaneous actinic damage in carcinogenesis on KTRs and highlight the significance of individualized periodic dermatological screening.

scholarly journals Weak antibody response to 3 doses of mRNA vaccine in kidney transplant recipients treated with belatacept

2021 ◽  
Author(s):  
Nathalie Chavarot ◽  
Antoine Morel ◽  
Marianne Leruez‐Ville ◽  
Estelle Villain ◽  
Gillian Divard ◽  
...  
Keyword(s):  
Antibody Response ◽  
Kidney Transplant ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients
Sign in / Sign up

Export Citation Format

Share Document